Sponsored by
Latest
Topics
Topics
Accounting & Tax
Corporate Finance
Human Capital
Risk & Compliance
Strategy
Technology
Featured
Auditing
The Big Four Continue to Dominate Auditing: Weekly Stat
The audit market is most concentrated among the population of large accelerated filers, 88% of which tap a Big Four firm for assurance.
By
Vincent Ryan
| June 29, 2022
Read More
Resources
CFO Live
Sign Up
Menu
Topics
Accounting & Tax
Corporate Finance
Human Capital
Risk & Compliance
Strategy
Technology
Explore
Search
Latest
Resources
CFO Live
Sign Up
Sponsored by
Daniel O'Day
M&A
Gilead to Buy Cancer Drugmaker for $21 Billion
The acquisition of Immunomedics "represents significant progress in Gilead’s work to build a strong and diverse oncology portfolio."
By
Matthew Heller
| September 14, 2020
Read More
Strategy
Gilead to Invest $5B in Galapagos Partnership
The deal expands Gilead's investment in the European biotech as it seeks to add assets to its drug portfolio.
By
Matthew Heller
| July 15, 2019
Read More
Technology
Roche Buys Flatiron in $1.9B ‘Big Data’ Move
The real-world evidence Flatiron's record system collects "is a key ingredient to accelerate the development of, and access to, new cancer treatments."
By
Matthew Heller
| February 15, 2018
Read More